Related Experiment Video

Updated: Aug 15, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Prevalence and Treatment of Hypertension Complicated by Comorbid Conditions

Joy L. Meier1, Julio Lopez, David Siegel

  • 1Pharmacy Service Department of Veterans Affairs, Northern California Health Care System, Martinez, CA and School of Pharmacy, University of the Pacific, Stockton, CA.

Journal of Clinical Hypertension (Greenwich, Conn.)
|June 21, 2001
PubMed

Insights

Comorbid conditions like heart disease and diabetes are common in hypertensive patients, yet they rarely influence the choice of blood pressure medication. Most patients receive calcium antagonists or ACE inhibitors regardless of other health issues.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Comorbid conditions are prevalent in patients with hypertension.
  • The impact of these conditions on antihypertensive prescribing patterns is not well-understood.
  • Understanding these factors is crucial for optimizing patient care.

Purpose of the Study:

  • To determine the prevalence of comorbid conditions in hypertensive patients.
  • To investigate whether comorbid conditions influence antihypertensive prescribing.
  • To analyze prescribing patterns for common antihypertensive agents.

Main Methods:

  • Retrospective analysis of 7526 patients receiving antihypertensive medication.
  • Data collected from four Department of Veterans Affairs clinics.
  • Prevalence of coronary artery disease (CAD), diabetes mellitus (DM), COPD/asthma, and congestive heart failure (CHF) assessed.

Main Results:

  • High prevalence of CAD (33%), DM (32%), COPD/asthma (21%), and CHF (13%) noted.
  • Comorbid conditions had minimal impact on antihypertensive agent selection.
  • Calcium antagonists and ACE inhibitors were the most frequently prescribed agents.
  • Beta-blocker use was not significantly influenced by the presence of CAD.

Conclusions:

  • Current antihypertensive prescribing practices may not adequately account for comorbid conditions.
  • Further research is needed to align treatment with patient complexity.
  • Optimizing therapy based on comorbidities could improve outcomes for hypertensive patients.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.